Effects of angiogenic growth factors and a penetrance enhancer on composite grafts

Annals of Otology, Rhinology and Laryngology

Volumn 107, Issue 9 II, 1998, Pages 769-774

  Hom, David B ^a,b   Winters, Margaret ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Graft; Graft survival; Growth substance; Vascularization

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DIMETHYL SULFOXIDE; ENDOTHELIAL CELL GROWTH FACTOR;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; DRUG EFFECT; GRAFT SURVIVAL; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN ABRASION; SKIN FLAP; SKIN GRAFT; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL TECHNIQUE; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANGIOGRAPHY; ANIMALS; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GRAFT SURVIVAL; HUMANS; INJECTIONS, INTRADERMAL; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; SKIN TRANSPLANTATION; SURGICAL FLAPS;

EID: 0031684892     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949810700906     Document Type: Article

References (22)

1. Brown J, Cannon B. Composite free graft of skin and cartilage from ear. Surg Gynecol Obstet 1946;82:253-5.
2. MacCollum M, Grabb W. Increasing the incidence and size of successful experimental composite ear grafts by advance preparation of the recipient bed. Plast Reconstr Surg 1977;60:759-62.
3. Hartman D, Goode R. Pharmacologic enhancement of composite graft survival. Arch Otolaryngol Head Neck Surg 1987;113:720-3.
4. Aden K, Biel M. The evaluation of pharmacologic agents on composite graft survival. Arch Otolaryngol Head Neck Surg 1992;118:175-8.
5. Henrich DE, Logan TC, Lewis RS, Shockley WW. Composite graft survival. An auricular amputation model. Arch Otolaryngol Head Neck Surg 1995;121:1137-42.
6. Folkman J, Klagsbrun M. Anaiogenic factors. Science 1987;235:442-7.
7. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC, Shaw WW, Centre NY. The effect of basic fibroblast growth factor on the neovascularisation process: skin flap survival and staged Hap transfers. Br J Plast Surg 1991;44:585-8.
8. Horn DB, Assefa G. Effects of endothelial cell growth factor on vascular compromised skin flaps. Arch Otolarynsol Head Neck Surg 1992;118:624-8.
9. Baird A, Walicke P. Fibroblast growth factors. Br Med Bull 1989;45:438-52.
10. Cuevas P, Burges J, Baird A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun 1988;156:611-8.
11. Chien Y, Liu J. Transdermal drug delivery systems. J Biomater Appl 1986;1:183-205.
12. Kazim M, Weber C, Strausberg L, La Foret G, Reemtsma K. Effect of topical insulin on blood glucose of diabetic mice. Surg Forum 1984;35:64-6.
13. Weber C, Jicha D, Matz S, et al. Passage of somatostatin analogues across human and mouse skin. Surgery 1987;102: 974-81.
14. Sodicoff M, Lamperti A, Ziskin M. Transdermal absorption of radioprotectors using permeation-enhancing vehicles. Radiat Res 1990;121:212-9.
15. Arden RL, Smith DM, Salley SO, Sakr WA, Doerr TD. Survival of composite chondrocutaneous grafts by vessel implantation: a study in the rabbit ear model. Laryngoscope 1995;105:1326-33.
16. Clairmont M, Conley JJ. The uses and limitations of auricular composite grafts. J Otolaryngol 1978;7:249-56.
17. Smith RO, Dickinson JT, Cipcic JA. Composite grafts in facial reconstructive surgery. Arch Otolaryngol 1972;95:252-64.
18. Rees TD. The transfer of free composite grafts of skin and fat: a clinical study. Plast Reconstr Surg 1960;25:556-64.
19. Ballantyne D, Converse J. Vascularization of composite auricular grafts transplanted to the chorioallantois of the chick embryo. Transpl Bull 1958;5:373-7.
20. Rees T, Converse J, Guy C. Composite grafts. Transactions of the Third International Congress of Plastic and Reconstructive Surgery, Washington, DC, 1963.
21. Berti J, Lipsky J. Transcutaneous drug delivery. Mayo Clin Proc 1995;70:581-6.
22. Lebredo L, Barrie R, Woltering E. DMSO protects against Adriamycin-induced tissue necrosis. J Surg Res 1992;53:62-5.